HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ann M Hopkins Selected Research

tetrocarcin A

3/2019Antibiotic Tetrocarcin-A Down-regulates JAM-A, IAPs and Induces Apoptosis in Triple-negative Breast Cancer Models.
1/2019Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ann M Hopkins Research Topics

Disease

11Breast Neoplasms (Breast Cancer)
03/2021 - 09/2009
8Neoplasms (Cancer)
03/2022 - 08/2015
5Neoplasm Metastasis (Metastasis)
11/2020 - 03/2011
3Inflammation (Inflammations)
04/2012 - 12/2003
2Noninfiltrating Intraductal Carcinoma (DCIS)
03/2022 - 02/2014
2Wounds and Injuries (Trauma)
12/2021 - 10/2004
2Triple Negative Breast Neoplasms
03/2019 - 02/2018
1Breast Ductal Carcinoma
03/2022
1Vasculitis (Vasculitides)
12/2021
1Stomach Neoplasms (Stomach Cancer)
03/2021
1Esophageal Neoplasms (Esophageal Cancer)
03/2021
1Brain Diseases (Brain Disorder)
11/2020
1Lung Neoplasms (Lung Cancer)
01/2019
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2018
1Melanoma (Melanoma, Malignant)
01/2018
1Ductal Carcinoma
02/2014
1Carcinogenesis
10/2013
1Colitis
04/2012
1Spontaneous Perforation
07/2008
1Anastomotic Leak
07/2008
1Esophageal Perforation
07/2008
1Cysts
06/2008
1Gastritis
03/2002

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
12/2021 - 09/2009
7Junctional Adhesion Molecule AIBA
03/2022 - 03/2011
7Epidermal Growth Factor (EGF)IBA
03/2022 - 02/2018
3Anti-Bacterial Agents (Antibiotics)IBA
03/2019 - 03/2002
3LipidsIBA
02/2014 - 04/2012
2Lapatinib (GW572016)FDA Link
03/2022 - 11/2018
2Messenger RNA (mRNA)IBA
01/2022 - 03/2021
2Biomarkers (Surrogate Marker)IBA
03/2021 - 10/2013
2Pharmaceutical PreparationsIBA
11/2020 - 11/2018
2tetrocarcin AIBA
03/2019 - 01/2019
2Actins (F Actin)IBA
06/2008 - 10/2004
2CytokinesIBA
10/2004 - 12/2003
1Phosphotransferases (Kinase)IBA
03/2022
1EnzymesIBA
12/2021
1beta CateninIBA
02/2021
1LigandsIBA
11/2020
1Peptides (Polypeptides)IBA
11/2020
1Inhibitor of Apoptosis ProteinsIBA
01/2019
1Tight Junction ProteinsIBA
01/2019
1Trastuzumab (Herceptin)FDA Link
11/2018
1compound C4 (Crassin)IBA
02/2018
1DiterpenesIBA
02/2018
1Cell Surface ReceptorsIBA
02/2018
1Estrogen ReceptorsIBA
02/2018
1Progesterone Receptors (Progesterone Receptor)IBA
02/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2018
1Cytostatic AgentsIBA
02/2018
1copanlisibIBA
01/2018
1AfatinibIBA
01/2018
1ezrinIBA
12/2012
1Fibronectins (Fibronectin)IBA
03/2011
1GTP Phosphohydrolases (GTPases)IBA
03/2011
1Small Interfering RNA (siRNA)IBA
09/2009
1Phenobarbital (Luminal)FDA Link
06/2008
1Myosin Type IIIBA
06/2008
1Cysteine Proteases (Cysteine Protease)IBA
11/2007
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2003
1Proton Pump InhibitorsIBA
03/2002

Therapy/Procedure

6Therapeutics
03/2022 - 03/2002
1Fundoplication
07/2008
1Gastrectomy
07/2008
1Stents
07/2008
1Esophagectomy
07/2008